Advertisement
Advertisement

RGC

RGC logo

Regencell Bioscience Holdings Ltd

4.91
USD
+0.04
+0.82%
Dec 18, 15:59 UTC -5
Closed
...

Regencell Bioscience Holdings Ltd Profile

About

Regencell Bioscience Holdings Limited is an early-stage bioscience company which focuses on research, development and commercialization of Traditional Chinese Medicine for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder. Regencell Bioscience Holdings Limited is based in HONG KONG.

Info & Links

CEO

Yat-Gai Au

Headquarters

9/F CHINACHEM LEIGHTON PLAZA, 29 LEIGHTON ROAD CAUSEWAY BAY
HONG KONG, K3 999077, HONG KONG

Auditor

Marcum Asia CPAs LLP

Share holders

--

Employees

12

Regencell Bioscience Holdings Ltd Statistics

Valuation Measures

Market Capitalization2

63.88M

Enterprise Value

60.92M

Enterprise Value/EBITDA(ttm)

--

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

8.44

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

--

Return on Invested Capital(ttm)

0.00%

Return on Assets(ttm)

--

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

0.00

Net Income Available to Common(ttm)

0.00

Diluted EPS(ttm)

--

Share Statistics

Beta (5Y Monthly)

-0.65

52-Week Change

-53.23%

S&P 500 52-Week Change

23.87%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

13.01M

Dividend Yield

0.00%

Float4

0.00

% Held by Insiders

--

% Held by Institutions

0.13%

Balance Sheet

Total Cash(mrq)

7.96M

Total Cash Per Share(mrq)

0.61

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

--

Quick Ratio(mrq)

41.92%

Book Value Per Share(mrq)

--

Cash Flow

Operating Cash Flow Per Share(ytd)

--

Free Cash Flow(ytd)

0.00

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement